##################################################################################
# Document Properties
##################################################################################
SET DOCUMENT Name = "32142651.bel"
SET DOCUMENT Authors = "Priya S"
SET DOCUMENT ContactInfo = "priya@causalitybiomodels.com"
SET DOCUMENT Description = "COVID Knowledge Curation project"

SET DOCUMENT Licenses = "Private Ownership to Fraunhofer Institute SCAI"
SET DOCUMENT Copyright = "Copyright Â© 2020 Fraunhofer Institute SCAI, All rights reserved"
SET DOCUMENT Version = "2.0.0"


##################################################################################
# NAMESPACES Section
##################################################################################
DEFINE NAMESPACE HGNC AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20190708.belns"
DEFINE NAMESPACE CHEBI AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns"
DEFINE NAMESPACE DO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20200407.belns"
DEFINE NAMESPACE MESH AS URL 	"https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns"
DEFINE NAMESPACE TAX AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-taxonomy/ncbi-taxonomy-20200322.belns"
#Not in template.bel
DEFINE NAMESPACE COVID AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-covid19/ncbi-covid19-20200326.belns"

DEFINE NAMESPACE UNIPROT AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"

##################################################################################
# ANNOTATIONS Section
##################################################################################
DEFINE ANNOTATION CellLine AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20190128.belanno"
DEFINE ANNOTATION Custom_CellLine AS LIST {"TMPRSS2-293T cells", "Vero-TMPRSS2 cells"}

# Document Annotations #
DEFINE ANNOTATION PublicationType AS LIST {"Research"}
DEFINE ANNOTATION PublicationStatus AS LIST {"Published"}
DEFINE ANNOTATION Section AS LIST {"Results"}
##################################################################################
# Statements #
#################################################################################

SET Citation = {"PubMed", "Cell. 2020 Mar 4. pii: S0092-8674(20)30229-4. doi: 10.1016/j.cell.2020.02.052.", "32142651"}

SET PublicationType = "Research"
SET PublicationStatus = "Published"
SET Section = "Results"

SET Evidence = "In agreement with these findings, directed expression of human and bat \
(Rhinolophus alcyone) ACE2 but not human DPP4, the entry receptor used \
by MERS-CoV (Raj et al., 2013), or human APN, the entry receptor used \
by HCoV-229E (Yeager et al.,1992), allowed SARS-2-S- and SARS-S-driven \
entry into otherwise non-susceptible BHK-21 cells (Figure 3A)."

SET CellLine = "BHK-21 cell"
complex(p(HGNC:DPP4), a(MESH:"Middle East Respiratory Syndrome Coronavirus")) reg a(MESH:"Middle East Respiratory Syndrome Coronavirus")
complex(p(HGNC:ANPEP),a(TAX:"Human coronavirus 229E")) reg a(TAX:"Human coronavirus 229E")
complex(p(HGNC:ACE2), p(COVID:S)) reg p(COVID:S)
p(COVID:S) -- a(TAX:"Severe acute respiratory syndrome coronavirus 2")
complex(p(HGNC:ACE2), a(UNIPROT:P59594)) reg a(UNIPROT:P59594)
UNSET CellLine

SET Evidence = "Moreover, antiserum raised against human ACE2 blocked SARS-S- and \
SARS-2-S- but not VSV-G- or MERS-S-driven entry (Figure 3B)."

SET CellLine = "Vero cell"
act(p(HGNC:ACE2)) pos a(UNIPROT:P59594)
act(p(HGNC:ACE2)) pos p(COVID:S)
UNSET CellLine

SET Evidence = "Ammonium chloride blocked VSV-G-dependent entry into both cell lines \
whereas entry driven by Nipah virus F and G proteins was not affected \
(Figure S3A; data not shown), consistent with Nipah virus but not VSV \
being able to fuse directly with the plasma membrane (Bossart et al., \
2002)."

SET Custom_CellLine = "TMPRSS2-293T cells"
SET CellLine = "Caco-2 cell"
a(CHEBI:"ammonium chloride") -| complex(p(HGNC:TMPRSS2), a(MESH:"G protein, vesicular stomatitis virus"))
UNSET CellLine
UNSET Custom_CellLine

SET Evidence = "Ammonium chloride treatment strongly inhibited SARS-2-S- and SARS-S- \
driven entry into TMPRSS2-293T cells (Figure S3 A), suggesting CatB/L \
dependence."

SET Custom_CellLine = "TMPRSS2-293T cells"
a(CHEBI:"ammonium chloride") -| complex(p(COVID:S), p(HGNC:ACE2))
a(CHEBI:"ammonium chloride") -| complex(p(HGNC:ACE2), a(UNIPROT:P59594))
UNSET Custom_CellLine

SET Evidence = "Indeed, the clinically proven serine protease inhibitor camostat \
mesylate, which is active against TMPRSS2 (Kawase et al., 2012), \
partially blocked SARS-2-S-driven entry into Caco-2 (Figure S3 B) and \
Vero-TMPRSS2 cells (Figure 4A)."

SET Custom_CellLine = "Vero-TMPRSS2 cells"
SET CellLine = "Caco-2 cell"
a(CHEBI:camostat) -| act(p(HGNC:TMPRSS2))
complex(a(CHEBI:camostat), p(HGNC:TMPRSS2)) -| p(COVID:S)
UNSET CellLine
UNSET Custom_CellLine

SET Evidence = "Full inhibition was attained when camostat mesylate and E-64d, an \
inhibitor of CatB/L, were added (Figure 4A; Figure S3B), indicating \
that SARS-2-S can use both CatB/L as well as TMPRSS2 for priming in \
these cell lines."

SET Custom_CellLine = "Vero-TMPRSS2 cells"
a(CHEBI:camostat) -| act(p(HGNC:CTSB))
a(CHEBI:camostat) -| act(p(HGNC:CTSL))
a(CHEBI:aloxistatin) -| act(p(HGNC:CTSB))
a(CHEBI:aloxistatin) -| act(p(HGNC:CTSL))
complex(p(HGNC:CTSB), p(COVID:S)) -> p(COVID:S)
complex(p(HGNC:CTSL), p(COVID:S)) -> p(COVID:S)
complex(p(HGNC:TMPRSS2), p(COVID:S)) -> p(COVID:S)
UNSET Custom_CellLine

SET Evidence = "Indeed, camostat mesylate significantly reduced MERS-S-, SARS-S-, and \
SARS-2-S- but not VSV-G-driven entry into the lung cell line Calu-3 \
(Figure 4C) and exerted no unwanted cytotoxic effects (Figure S3 C)."

SET CellLine = "Calu-3 cell"
a(CHEBI:camostat) -| a(UNIPROT:P59594)
a(CHEBI:camostat) -| p(COVID:S)
UNSET CellLine

SET Evidence = "Similarly, camostat mesylate treatment significantly reduced Calu-3 \
infection with authentic SARS-CoV-2 (Figure 4D)."

SET CellLine = "Calu-3 cell"
a(CHEBI:camostat) -| path(DO:"COVID-19")
UNSET CellLine

SET Evidence = "Finally, camostat mesylate treatment inhibited SARS-S- and SARS-2-S- \
but not VSV-G-driven entry into primary human lung cells (Figure 4E)."

SET CellLine = "Calu-3 cell"
a(CHEBI:camostat) -| p(COVID:S)
a(CHEBI:camostat) -| a(UNIPROT:P59594)
UNSET CellLine

SET Evidence = "Collectively, SARS-CoV-2 can use TMPRSS2 for S protein priming and \
camostat mesylate, an inhibitor of TMPRSS2, blocks SARS-CoV-2 \
infection of lung cells."

SET CellLine = "Calu-3 cell"
complex(p(HGNC:TMPRSS2), p(COVID:S)) -> p(COVID:S)
a(CHEBI:camostat) -| path(DO:"COVID-19")
UNSET CellLine

UNSET PublicationType
UNSET PublicationStatus
UNSET Section
